Tweenvest Stocks

SOPHiA GENETICS SA (NasdaqGS: SOPH)

Health Care · Health Care Technology · CH

$8.65

+2.37% today · +150.7% 1Y

SOPHiA GENETICS SA (NasdaqGS: SOPH) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $736.36M and employs 415 people.

Over the last twelve months the share price has gained 150.7%, trading between 3.10 and 8.31.

Tweenvest scores SOPHiA GENETICS SA across four factors: quality 33/100, value 60/100, growth 83/100. Its strongest factor is growth.

SOPH price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$736.36M
Revenue (TTM)
$86.17M
P/E
EPS
-1.16
Dividend yield
Beta (5Y)
0.92
52-week high
$8.31
52-week low
$3.10
Avg volume (3M)
Shares outstanding
85.13M
Employees
415
Next earnings

About SOPHiA GENETICS SA

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

ISIN
CH1125843347
Founded
2011
Listed since
Jul 23, 2021
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Veeva Systems Inc.NYSE: VEEV$40.09B$246.78-0.68%
Pro Medicus LimitedASX: PME$14.25BAU$190.60-1.46%
M3, Inc.TSE: 2413$7.33B¥1,750.00+1.77%
Sectra AB (publ)OM: SECT B$5.62BSkr276.20+0.15%
Waystar Holding Corp.NasdaqGS: WAY$4.64B$24.21-4.50%
Doximity, Inc.NYSE: DOCS$4.41B$24.74-2.21%
HeartFlow, Inc.NasdaqGS: HTFL$4.34B$49.89-0.62%
Inventurus Knowledge Solutions LimitedNSEI: IKS$3.30BRs1,840.00+6.43%

Browse every Health Care Technology company →

Figures last refreshed Aug 18, 2026.